Clinical Trial Update: Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of Birch pollen extract immunotherapy for allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Birch pollen extract immunotherapy (birch pollen extract)

Snippet

Sponsor: Medical University of Silesia | Conditions: Allergic Rhinitis, Allergic Reaction | Phase 3 | Status: COMPLETED